Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to -$139000.0.

  • Rockwell Medical's Change in Accured Expenses fell 14005.76% to -$139000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 265212.77%. This contributed to the annual value of -$1.0 million for FY2024, which is 17500.0% down from last year.
  • Per Rockwell Medical's latest filing, its Change in Accured Expenses stood at -$139000.0 for Q3 2025, which was down 14005.76% from -$503000.0 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Change in Accured Expenses ranged from a high of $2.9 million in Q3 2023 and a low of -$3.3 million during Q1 2023
  • Over the past 5 years, Rockwell Medical's median Change in Accured Expenses value was -$139000.0 (recorded in 2025), while the average stood at -$64631.6.
  • As far as peak fluctuations go, Rockwell Medical's Change in Accured Expenses soared by 60000.0% in 2021, and later plummeted by 41484.38% in 2023.
  • Rockwell Medical's Change in Accured Expenses (Quarter) stood at $777000.0 in 2021, then soared by 128.83% to $1.8 million in 2022, then plummeted by 63.05% to $657000.0 in 2023, then tumbled by 143.07% to -$283000.0 in 2024, then surged by 50.88% to -$139000.0 in 2025.
  • Its Change in Accured Expenses stands at -$139000.0 for Q3 2025, versus -$503000.0 for Q2 2025 and -$1.7 million for Q1 2025.